These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 32295454)
1. Diminished levels of the chemokine fractalkine in post-mortem prefrontal cortex in schizophrenia but not bipolar disorder. Hill SL; Shao L; Beasley CL World J Biol Psychiatry; 2021 Feb; 22(2):94-103. PubMed ID: 32295454 [TBL] [Abstract][Full Text] [Related]
2. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases. Luo P; Chu SF; Zhang Z; Xia CY; Chen NH Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784 [TBL] [Abstract][Full Text] [Related]
3. Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration. Zhang M; Xu G; Liu W; Ni Y; Zhou W PLoS One; 2012; 7(4):e35446. PubMed ID: 22536384 [TBL] [Abstract][Full Text] [Related]
4. The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system. Lowery RL; Tremblay ME; Hopkins BE; Majewska AK Glia; 2017 Nov; 65(11):1744-1761. PubMed ID: 28836393 [TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence. Fernández de Cossío L; Lacabanne C; Bordeleau M; Castino G; Kyriakakis P; Tremblay MÈ Brain Behav Immun; 2021 Oct; 97():440-454. PubMed ID: 34343619 [TBL] [Abstract][Full Text] [Related]
6. Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice. Kawamura N; Katsuura G; Yamada-Goto N; Novianti E; Inui A; Asakawa A BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33568358 [TBL] [Abstract][Full Text] [Related]
7. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
8. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death. Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090 [TBL] [Abstract][Full Text] [Related]
9. Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling. Gunner G; Cheadle L; Johnson KM; Ayata P; Badimon A; Mondo E; Nagy MA; Liu L; Bemiller SM; Kim KW; Lira SA; Lamb BT; Tapper AR; Ransohoff RM; Greenberg ME; Schaefer A; Schafer DP Nat Neurosci; 2019 Jul; 22(7):1075-1088. PubMed ID: 31209379 [TBL] [Abstract][Full Text] [Related]
10. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease. Camacho-Hernández NP; Peña-Ortega F Neural Plast; 2023; 2023():4637073. PubMed ID: 36644710 [TBL] [Abstract][Full Text] [Related]